Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Irish who wrote (5009)	4/25/1999 2:23:00 PM
From: Peter V	Respond to of 5736

Hello Irish, nice to see you again as well. It seems like you haven't been posting much on SI at all lately, except for a few comments about bid.com and a couple responses to Cacaito. But obviously you are monitoring the thread. So where are you hanging out these days? CCSI has got some momentum behind it lately, so it's worth looking at again. Hope your weekend was good as well. Good luck. Peter

To: Irish who wrote (5009)	4/28/1999 8:40:00 AM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

News - European Union CE Mark Certification CHROMATICS COLOR SCIENCES RECEIVES EUROPEAN UNION CE MARK CERTIFICATION NEW YORK, April 28 /PRNewswire/ -- Chromatics Color Sciences International, Inc. (Nasdaq: CCSI) announced that it received notice on April 27, 1999 that it was granted permission on April 7, 1999 by the European Union (EU) notified body, TUV Essen, to affix the CE Mark to its Colormate(R) TLc.BiliTest(TM) System product line. Display of the CE Mark is evidence that the Company's medical products meet EU medical device requirements and is a prerequisite for purposes of commercial distribution within the EU. With this grant of permission, there is no need for specific product type or lot inspections by the notified body. Among other things, to be granted such permission the Company passed a full quality assurance system audit by the notified body, TUV Essen, including a technical file review confirming the Company's system for the design, development, production, installations and servicing of its medical products meets strict international safety requirements. Chromatics Chief Executive Officer Darby Macfarlane said, "We are very pleased to have received this key approval. While specifically supporting our efforts to market the Colormate(R) TLc.BiliTest(TM System in Europe, this development further demonstrates to the medical community worldwide the extent of our quality commitment overall." In March, CCSI announced that its design control process had received the ISO-9001 and EN46001 certifications, signifying that it had met important quality standards. The Company previously announced that its contract manufacturer also has an ISO-9001 and EN46001-certified facility. The Colormate(R) TLc.BiliTest(TM) System is manufactured by the Company's contract manufacturer in accordance with ISO-9001 and EN46001 regulatory standards and the U.S. Food and Drug Administration's (FDA) Quality System Regulation (QSR), which enumerates current good manufacturing practices governing the methods used in, and the facilities and controls used for, the design, manufacture, packaging, labeling, storage, installation and servicing of finished medical devices for U.S. distribution. The Colormate(R) TLc.BiliTest(TM) System (TLc for tender, loving care is the only device with FDA clearance for commercial use, marketed in the U.S. for pain-free, non-invasive monitoring of hyperbilirubinemia for babies of all races and all gestational ages -- even when undergoing phototherapy treatment. A study of the device published in Pediatrics, the publication of the American Academy of Pediatrics, found that Colormate(R) TLc.BiliTest(TM) System results correlate within a clinically useful range to results obtained from current invasive techniques that involve taking blood from infants -- often repeatedly. Chromatics Color Sciences is in the business of color science.... Certain of the matters discussed in this announcement contain forward-looking .....